Researchers from the Stowers Institute for Medical Research and collaborators have identified a way to expand blood-forming, adult stem cells from human umbilical cord blood. Life-saving bone marrow transplants have been the common practice for decades, but this doesn’t work for everybody. Those kinds of genetic mutations could lead to the re-genesis of leukemia or cancer. These findings represent a major advance in the field and have significant potential to improve the outcomes of thousands of children and adults who undergo umbilical cord blood transplantation every year
- In current medicine, stem cells are the most promising area for the use of technology.
- One of the technologies, OpRegen1, is being tested on patients that have a more advanced form of the disease.
- The disease has been found to affect about 2% of Americans that are older than 50 years of age.
“Preserving the fovea at the very center of the macula is especially important. When cells in this tiny spot die, the patient has difficulty with everyday tasks.”